Sartorius Stedim Biotech Stock Equity Positions Weight
DIM Stock | EUR 199.00 0.35 0.18% |
Sartorius Stedim Biotech fundamentals help investors to digest information that contributes to Sartorius Stedim's financial success or failures. It also enables traders to predict the movement of Sartorius Stock. The fundamental analysis module provides a way to measure Sartorius Stedim's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sartorius Stedim stock.
Sartorius |
Sartorius Stedim Biotech Company Equity Positions Weight Analysis
Sartorius Stedim's Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
Competition |
According to the company disclosure, Sartorius Stedim Biotech has an Equity Positions Weight of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Instruments & Supplies (which currently averages 0.0) industry. This indicator is about the same for all France stocks average (which is currently at 0.0).
Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
All Next | Launch Module |
Sartorius Fundamentals
Return On Equity | 0.41 | |||
Return On Asset | 0.15 | |||
Profit Margin | 0.25 % | |||
Operating Margin | 0.32 % | |||
Current Valuation | 31.28 B | |||
Shares Outstanding | 92.17 M | |||
Shares Owned By Insiders | 73.81 % | |||
Shares Owned By Institutions | 13.83 % | |||
Price To Earning | 80.53 X | |||
Price To Book | 13.32 X | |||
Price To Sales | 8.58 X | |||
Revenue | 3.49 B | |||
Gross Profit | 1.83 B | |||
EBITDA | 1.33 B | |||
Net Income | 1.13 B | |||
Cash And Equivalents | 161.7 M | |||
Cash Per Share | 1.75 X | |||
Total Debt | 1.02 B | |||
Debt To Equity | 0.50 % | |||
Current Ratio | 1.49 X | |||
Book Value Per Share | 26.58 X | |||
Cash Flow From Operations | 612.3 M | |||
Earnings Per Share | 9.52 X | |||
Price To Earnings To Growth | 3.36 X | |||
Target Price | 412.2 | |||
Number Of Employees | 11.93 K | |||
Beta | 0.45 | |||
Market Capitalization | 28.45 B | |||
Total Asset | 5.07 B | |||
Retained Earnings | 462 M | |||
Working Capital | 122 M | |||
Current Asset | 439 M | |||
Current Liabilities | 317 M | |||
Z Score | 16.2 | |||
Annual Yield | 0 % | |||
Five Year Return | 0.57 % | |||
Net Asset | 5.07 B | |||
Last Dividend Paid | 1.44 |
About Sartorius Stedim Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sartorius Stedim Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sartorius Stedim using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sartorius Stedim Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sartorius Stock
Sartorius Stedim financial ratios help investors to determine whether Sartorius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.